The European gonococcal antimicrobial surveillance programme (Euro-GASP) appropriately reflects the antimicrobial resistance situation for Neisseria gonorrhoeae in the European Union/European Economic Area
Cole, M.J., Quinten, C., Jacobsson, S., Day, M., Amato-Gauci, A.J., Woodford, N., Spiteri, G., Unemo, M., Stary, A., Haller, M., Verbrugge, R., Crucitti, T., Soteriou, S., Pieridou, D., Cowan, S., Hoffmann, S., Epstein, J., Viktorova, J., Ndeikoundam, N., Goubard, A., Kohl, P., Buder, S., Bremer, V., Tzelepi, E., Konte, V., Balla, E., Dudás, M., Sigmundsdóttir, G., Hauksdóttir, G.S., Igoe, D., Crowley, B., Suligoi, B., Stefanelli, P., Pakarna, G., Mavcutko, V., Barbara, C., Melillo, J.M., Van Dam, A., Van Benthem, B., Linde, I., Kløvstad, H., Bergheim, T., Majewski, S., Mlynarczyk-Bonikowska, B., Azevedo, J., Borrego, M.J., Pavlik, P., Truska, P., Klavs, I., Jeverica, S., Vazquez, J., Diez, M., Velicko, I., Unemo, M., Hughes, G., Eastick, K.
Application of a new methodology and R package reveals a high burden of healthcare-associated infections (HAI) in Germany compared to the average in the European Union/European Economic Area, 2011 to 2012
Zacher, B., Haller, S., Willrich, N., Walter, J., Abu Sin, M., Cassini, A., Plachouras, D., Suetens, C., Behnke, M., Gastmeier, P., Wieler, L.H., Eckmanns, T.
Population-level antimicrobial consumption is associated with decreased antimicrobial susceptibility in Neisseria gonorrhoeae in 24 European countries: an ecological analysis.
Kenyon, C., Buyze, J., Spiteri, G., Cole, M.J., Unemo, M.
Development of case vignettes for assessment of the inter-rater variability of national validation teams for the point prevalence survey of healthcare-associated infections and antimicrobial use in European acute care hospitals
van Hauwermeiren, E., Iosifidis, E., Kärki, T., Suetens, C., Kinross, P., Plachouras, D.
Infographic: Antibiotic resistance – an increasing threat to human health
Each year, 33000 people die from an infection due to bacteria resistant to antibiotics. The burden of infections with bacteria resistant to antibiotics on the European population is comparable to that of inﬂuenza, tuberculosis and HIV/AIDS combined.
Infographic: Healthcare-associated infections – a threat to patient safety in Europe
A total of 8.9 million healthcare-associated infections were estimated to occur each year in European hospitals and long-term care facilities.
Antimicrobial use in European acute care hospitals: results from the second point prevalence survey (PPS) of healthcare-associated infections and antimicrobial use, 2016 to 2017
Plachouras, D., Kärki, T., Hansen, S., Hopkins, S., Lyytikäinen, O., Moro, M.L., Reilly, J., Zarb, P., Zingg, W., Kinross, P., Weist, K., Monnet, D.L., Suetens, C., The Point Prevalence Survey Study Group
Antimicrobial use in European long-term care facilities: results from the third point prevalence survey of healthcare-associated infections and antimicrobial use, 2016 to 2017
Ricchizzi, E., Latour, K., Kärki, T., Buttazzi, R., Jans, B., Moro, M.L., Nakitanda, O.A., Plachouras, D., Monnet, D.L., Suetens, C., Kinross, P., The Halt Study Group
Systematic review of the effectiveness of infection control measures to prevent the transmission of carbapenemase-producing Enterobacteriaceae through cross-border transfer of patients
The goal of this systematic review is to update the 2011 ECDC risk assessment. Evidence from this review will be used to develop guidance on this topic.
Systematic review of the effectiveness of infection control measures to prevent the transmission of extended-spectrum beta-lactamase-producing Enterobacteriaceae through cross-border transfer of patients
This systematic review seeks to identify evidence for the effectiveness of targeted infection control measures to control the spread and transmission of ESBL-E when transferring patients between healthcare settings, especially when the transfer is cross-border.